Yahoo Web Search

  1. Royal Navy admiral

Search results

  1. David B. Haslam, MD, is the director of the Antimicrobial Stewardship Program at Cincinnati Children's Hospital Medical Center. David B. Haslam, MD Schedule an Appointment

    • Male
    • (513) 803-1170
    • 3333 Burnet Ave, Cincinnati, 45229, OH
    • david.haslam@cchmc.org
  2. Sir David Anthony Haslam CBE FRCP FRCGP FAcadMEd (born 4 July 1949) [1] is a British medical doctor, writer and administrator. Education. Haslam was educated at the University of Birmingham (MB ChB, DObstRCOG, DFFP). [2] Medical career. Haslam worked for 36 years as a general practitioner in Ramsey, Cambridgeshire. [2]

  3. Dr. David B. Haslam is a Pediatric Infectious Disease Specialist in Cincinnati, OH. Find Dr. Haslam's phone number, address, insurance information, hospital affiliations and more.

    • (10)
    • (513) 636-4578
    • Cincinnati, OH
  4. Aug 22, 2019 · Pharmaceutical Executive APEX Awards. | Latest Executive Roundtables. Looking Back at NICE: Sir David Haslam. August 22, 2019. Leela Barham. Article. Leela Barham talks to Sir David Haslam, the outgoing Chair of UK’s National Institute for Health and Care Excellence (NICE), about the highs and lows of his six-year tenure at the organization.

    • Leela Barham
  5. en.wikipedia.org › wiki › Dave_HaslamDave Haslam - Wikipedia

    Dave Haslam is a British writer, broadcaster and DJ who DJed over 450 times at the Haçienda nightclub in Manchester and has since DJed worldwide. He has written for the New Musical Express, The Guardian, the London Review of Books and The Times, and has published five books. Life and career [ edit]

  6. David B. Haslam's 161 research works with 3,311 citations and 7,000 reads, including: The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve ...

  7. Oct 1, 2014 · NICE's David Haslam discusses the UK drug watchdog's new challenge in meeting expectations around what quantitative calculations of value mean to patient access today. New leadership is finally settling in at what is arguably the world's most prominent arbiter of pharmaceuticals pricing and access—the UK's National Institute of Health and ...

  1. People also search for